ALKERMES | ALKS - Devedores Comerciais

Preço das Ações
33.31
Mudança Diária
-0.60 -1.77%
Mensal
13.42%
Anual
19.65%
Q2 Previsão
32.32




Devedores Comerciais Alterar Data
AbbVie USD 12.77B 132M 2025-09
Acadia Pharmaceuticals USD 148.23M 8.79M 2025-12
ALKERMES USD 334.02M 21.08M 2025-12
Amgen USD 9.57B 1.08B 2025-12
Biogen USD 1.85B 234M 2025-09
BioMarin Pharmaceutical USD 908.21M 117.95M 2025-12
Bristol-Myers Squibb USD 14.62B 485M 2025-09
Coherus Biosciences USD 18.42M 232.08M 2025-12
Eli Lilly USD 19.46B 2.25B 2025-09
Gilead Sciences USD 4.91B 182M 2025-12
Heron Therapeutics USD 89.59M 8.54M 2025-12
Ionis Pharmaceuticals USD 66M 41.39M 2025-12
J&J USD 21.33B 3.72B 2025-12
Malin Corporation EUR 500K 300K 2024-12
Merck USD 12.12B 596M 2025-09
Nektar Therapeutics USD 1.78M 1.12M 2025-12
Neurocrine Biosciences USD 686.8M 41.2M 2025-12
Otsuka Holdings JPY 570.32B 39.96B 2025-12
Ovoca Bio EUR 39K 408K 2025-06
Pfizer USD 18.12B 2.02B 2025-09
Regeneron Pharmaceuticals USD 5.74B 54M 2025-12
Vertex Pharmaceuticals USD 2.05B 106.4M 2025-12